Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution
Viruses · 2025
DOI: 10.3390/v17070938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Sara Bolognini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Phage Therapy, Pseudomonas Phages, Pseudomonas Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, PNRR THE e Tuscany Health Ecosystem.
Abstract (Originalsprache)
Pseudomonas aeruginosa is a major opportunistic pathogen with high levels of antibiotic resistance. Phage therapy represents a promising alternative for the treatment of difficult infections both alone and in combination with antibiotics. Here, we isolated and characterized three novel lytic myoviruses, Cisa, Nello, and Moonstruck. Genomic analysis revealed that Cisa and Nello belong to the Pbunavirus genus, while Moonstruck is a novel Pakpunavirus species. All lacked lysogeny, virulence, or resistance-associated genes, supporting their therapeutic suitability. Phage Nello and Moonstruck were active against P. aeruginosa Pa3GrPv, isolated from a patient with lung infection candidate for phage therapy. Moonstruck exhibited superior lytic activity with ciprofloxacin sub-MIC value (0.125 µg/mL), achieving bacterial suppression for 48 h. However, to improve the lytic efficacy of the phages on the clinical isolate, phage adaptation via serial passage was investigated. The killing efficacy of Nello was enhanced, whereas Moonstruck showed a less consistent improvement, suggesting phage-specific differences in evolutionary dynamics. Sequencing of the evolved phages revealed point mutations in tail-associated genes, potentially linked to a better phage–host interaction. These results support the use of phage–antibiotic combinations and directed evolution as strategies to enhance phage efficacy against drug-resistant infections. Overall, these findings support the therapeutic potential of the newly isolated phages in treating P. aeruginosa lung infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Pisa, 56126 Pisa, Italy.
- Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
- National Centre for Innovative Technologies in Public Health, National Institute of Health, 00161 Rome, Italy.
ORCID-Profile: Sara Bolognini, Claudia Campobasso, Magda Marchetti, Laura Rindi, Arianna Tavanti, Mariagrazia Di Luca
Förderung
- Italian Ministry of Health
- PNRR THE e Tuscany Health Ecosystem
Zitieren
APA
Bolognini, S., Ferretti, C., Campobasso, C., Trovato, E., Marchetti, M., Rindi, L., Tavanti, A., & Di Luca, M. (2025). Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution. Viruses. https://doi.org/10.3390/v17070938
Vancouver
Bolognini S, Ferretti C, Campobasso C, Trovato E, Marchetti M, Rindi L, et al. Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution. Viruses. 2025. doi:10.3390/v17070938
BibTeX
@article{Bolognini2025,
author = {Bolognini, Sara and Ferretti, Caterina and Campobasso, Claudia and Trovato, Elisabetta and Marchetti, Magda and Rindi, Laura and Tavanti, Arianna and Di Luca, Mariagrazia},
title = {Therapeutic Optimization of Pseudomonas aeruginosa Phages: From Isolation to Directed Evolution},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17070938}
}
EUVIMED